Conference Coverage
-
Conference Coverage
Opioids for headache?
Two neurologists came to very difficult conclusions over whether opioids should be considered for headache treatment.
Latest News
-
From the Journals
Diabetes tied to Parkinson’s risk, more rapid disease progression
Diabetes is associated with a higher risk for incident Parkinson’s disease and with worse motor symptoms, more rapid disease progression, new...
-
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
-
From the Journals
Even light physical activity linked to lower dementia risk
-
Latest News
Positive phase 3 topline results for early Parkinson’s drug
“The initiation of treatment of patients with Parkinson’s disease represents an area of unmet need due to the side effects associated with current...
-
From the Journals
Coronavirus can spread to heart, brain days after infection
-
From the Journals
New data support a causal role for depression in Alzheimer’s
“If we can treat the depression early on, we may help reduce risk for dementia for our patients later in life,” said coinvestigator Dr. Aliza P....
-
From the Journals
Posttraumatic epilepsy is common, even after ‘mild’ TBI
“This prospective observational study confirms the epidemiologic data that even after mild brain injury, there is an increased risk for epilepsy...
-
News from the FDA/CDC
FDA OKs new adult insomnia med
Whereas the overall results are very positive, the improvements in daytime functioning are especially “exciting.”
-
From the Journals
Is outpatient care as safe as inpatient for TIA, minor stroke?
The safety of outpatient care can be improved by correct risk stratification, then triaging patients based on their risk profile.
-
From the Journals
Global dementia cases may triple by 2050 unless risk factors are reduced
By 2050, 153 million people are expected to have dementia worldwide – up from 57 million in 2019.
-
Latest News
Epstein-Barr virus a likely leading cause of multiple sclerosis
This study is the first to provide compelling evidence of a causal link between EBV and MS.
FDA/CDC
-
FDA/CDC
FDA approves new myasthenia gravis drug
This approval represents “an important step in providing a novel therapy option” for patients with the rare disease.
Guidelines
-
Guidelines
AAN updates treatment guidance on painful diabetic neuropathy
The guideline recommends offering one of four classes of oral medications found to be effective for neuropathic pain.
Literature Review
-
Literature Review
MRI is key to diagnosing CTE in living patients?
The findings represent an important first step in diagnosing CTE, but is the conclusion ‘overstated’?
-
Literature Review
Ketamine nasal spray provides slow-acting relief for cluster headache attacks
This proof-of-concept trial provides “critical information and paves the way for subsequent placebo-controlled studies.”
News
-
News
Medicare intends to limit payment for controversial Alzheimer’s drug
The decision marks something of a shift in Medicare’s approach to paying for medications.